Therapeutic potential of low-dose rosiglitazone in periodontitis: attenuation of inflammation and bone loss through macrophage reprogramming
Abstract Objectives This study aimed to investigate the effects of different dosages of the peroxisome proliferator-activated receptor gamma (PPAR-γ) agonist rosiglitazone on macrophage polarization, the expression of related inflammatory factors, and alveolar bone loss in the periodontal tissues of...
Gardado en:
| Principais autores: | , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
BMC
2026-04-01
|
| Series: | BMC Oral Health |
| Assuntos: | |
| Acceso en liña: | https://doi.org/10.1186/s12903-026-08251-4 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|